Study of Envafolimab Alone or With Lenvatinib in Patients With Advanced Endometrial Cancer
Clinical trial NCT05112991 · RECRUITING
Trial details
- NCT number
- NCT05112991
- Sponsor
- 3D Medicines (Sichuan) Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-04
- Primary completion
- 2026-12-01
- Enrollment
- 108
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.